A detailed history of Azzad Asset Management Inc /Adv transactions in Eli Lilly & CO stock. As of the latest transaction made, Azzad Asset Management Inc /Adv holds 1,735 shares of LLY stock, worth $1.58 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
1,735
Previous 1,814 4.36%
Holding current value
$1.58 Million
Previous $1.41 Billion 11.3%
% of portfolio
0.19%
Previous 0.16%

Shares

48 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$724.87 - $909.04 $57,264 - $71,814
-79 Reduced 4.36%
1,735 $1.57 Billion
Q1 2024

Apr 19, 2024

BUY
$592.2 - $792.28 $26,649 - $35,652
45 Added 2.54%
1,814 $1.41 Billion
Q4 2023

Apr 01, 2024

BUY
$525.19 - $619.13 $327,193 - $385,717
623 Added 54.36%
1,769 $1.03 Billion
Q3 2023

Apr 01, 2024

BUY
$434.7 - $599.3 $46,078 - $63,525
106 Added 10.19%
1,146 $616 Million
Q2 2023

Apr 01, 2024

SELL
$350.74 - $468.98 $52,260 - $69,878
-149 Reduced 12.53%
1,040 $488 Million
Q1 2023

Apr 01, 2024

SELL
$310.63 - $364.82 $20,812 - $24,442
-67 Reduced 5.33%
1,189 $408 Million
Q4 2022

Apr 01, 2024

SELL
$321.55 - $374.67 $3.46 Million - $4.03 Million
-10,757 Reduced 89.54%
1,256 $460 Million
Q3 2022

Apr 01, 2024

SELL
$296.48 - $337.87 $994,690 - $1.13 Million
-3,355 Reduced 21.83%
12,013 $2.17 Billion
Q2 2022

Apr 01, 2024

BUY
$278.73 - $327.27 $3.14 Million - $3.69 Million
11,279 Added 275.84%
15,368 $3.26 Billion
Q1 2022

Apr 01, 2024

BUY
$234.69 - $291.66 $150,201 - $186,662
640 Added 18.56%
4,089 $1.17 Billion
Q4 2021

Apr 01, 2024

SELL
$224.85 - $279.04 $30,129 - $37,391
-134 Reduced 3.74%
3,449 $953 Million
Q3 2021

Apr 01, 2024

BUY
$221.6 - $272.71 $35,899 - $44,179
162 Added 4.74%
3,583 $828 Million
Q2 2021

Apr 01, 2024

SELL
$180.55 - $233.54 $4,333 - $5,604
-24 Reduced 0.7%
3,421 $785 Million
Q1 2021

Apr 01, 2024

SELL
$164.32 - $212.72 $1.47 Million - $1.9 Million
-8,954 Reduced 72.22%
3,445 $644 Million
Q4 2020

Apr 01, 2024

BUY
$130.46 - $172.63 $17,351 - $22,959
133 Added 1.08%
12,399 $2.09 Billion
Q3 2020

Apr 01, 2024

BUY
$146.22 - $169.13 $218,452 - $252,680
1,494 Added 13.87%
12,266 $1.82 Billion
Q2 2020

Apr 01, 2024

SELL
$136.42 - $164.18 $175,572 - $211,299
-1,287 Reduced 10.67%
10,772 $1.77 Billion
Q1 2020

Apr 01, 2024

SELL
$119.05 - $147.35 $1.27 Million - $1.58 Million
-10,691 Reduced 46.99%
12,059 $1.67 Billion
Q4 2019

Apr 01, 2024

BUY
$106.92 - $132.43 $10,050 - $12,448
94 Added 0.41%
22,750 $3.34 Billion
Q3 2019

Apr 01, 2024

BUY
$106.79 - $116.16 $930,461 - $1.01 Million
8,713 Added 62.49%
22,656 $3.1 Billion
Q2 2019

Apr 01, 2024

SELL
$110.79 - $129.32 $5,650 - $6,595
-51 Reduced 0.36%
13,943 $1.54 Billion
Q1 2019

Apr 01, 2024

BUY
$111.31 - $131.02 $1,113 - $1,310
10 Added 0.07%
13,994 $1.82 Billion
Q4 2018

Apr 01, 2024

SELL
$105.9 - $118.64 $408,985 - $458,187
-3,862 Reduced 21.64%
13,984 $1.62 Billion
Q3 2018

Apr 01, 2024

SELL
$85.86 - $107.31 $19,232 - $24,037
-224 Reduced 1.24%
17,846 $1.92 Billion
Q2 2018

Apr 01, 2024

BUY
$75.7 - $86.88 $1.37 Million - $1.57 Million
18,070 New
18,070 $1.54 Billion
Q1 2018

Apr 03, 2024

BUY
$74.21 - $87.6 $30,055 - $35,478
405 Added 2.33%
17,766 $1.37 Billion
Q4 2017

Apr 03, 2024

BUY
$81.94 - $87.89 $27,204 - $29,179
332 Added 1.95%
17,361 $1.47 Billion
Q3 2017

Apr 03, 2024

BUY
$77.07 - $85.54 $44,700 - $49,613
580 Added 3.53%
17,029 $1.46 Billion
Q2 2017

Apr 03, 2024

BUY
N/A
2,464 Added 17.62%
16,449 $1.35 Billion
Q1 2017

Apr 03, 2024

BUY
N/A
579 Added 4.32%
13,985 $1.18 Billion
Q4 2016

Apr 03, 2024

SELL
N/A
-1,089 Reduced 7.51%
13,406 $986 Million
Q3 2016

Apr 03, 2024

SELL
N/A
-170 Reduced 1.16%
14,495 $1.16 Billion
Q2 2016

Apr 03, 2024

BUY
N/A
236 Added 1.64%
14,665 $1.15 Billion
Q1 2016

Apr 03, 2024

BUY
N/A
586 Added 4.23%
14,429 $1.04 Billion
Q4 2015

Apr 03, 2024

SELL
N/A
-1,447 Reduced 9.46%
13,843 $1.17 Billion
Q3 2015

Apr 03, 2024

SELL
N/A
-1,016 Reduced 6.23%
15,290 $1.28 Billion
Q2 2015

Apr 03, 2024

SELL
N/A
-2,113 Reduced 11.47%
16,306 $1.36 Billion
Q1 2015

Apr 03, 2024

BUY
N/A
798 Added 4.53%
18,419 $1.34 Billion
Q4 2014

Apr 03, 2024

BUY
N/A
3,502 Added 24.8%
17,621 $1.22 Billion
Q3 2014

Apr 03, 2024

BUY
N/A
8,303 Added 142.76%
14,119 $916 Million
Q2 2014

Apr 03, 2024

SELL
N/A
-19 Reduced 0.33%
5,816 $362 Million
Q1 2014

Apr 03, 2024

BUY
N/A
133 Added 2.33%
5,835 $343 Million
Q4 2013

Apr 03, 2024

BUY
N/A
406 Added 7.67%
5,702 $291 Million
Q2 2013

Apr 03, 2024

BUY
N/A
1,003 Added 23.36%
5,296 $267 Million
Q1 2013

Apr 03, 2024

BUY
N/A
2,524 Added 142.68%
4,293 $244 Million
Q2 2011

Apr 08, 2024

SELL
N/A
-6,539 Closed
0 $0
Q1 2011

Apr 08, 2024

SELL
N/A
-588 Reduced 8.25%
6,539 $230 Million
Q4 2010

Apr 08, 2024

BUY
N/A
5,358
7,127 $250 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $867B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Azzad Asset Management Inc /Adv Portfolio

Follow Azzad Asset Management Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.